BG107507A - Акридинови производни и тяхното използване като лекарствени средства - Google Patents

Акридинови производни и тяхното използване като лекарствени средства Download PDF

Info

Publication number
BG107507A
BG107507A BG107507A BG10750703A BG107507A BG 107507 A BG107507 A BG 107507A BG 107507 A BG107507 A BG 107507A BG 10750703 A BG10750703 A BG 10750703A BG 107507 A BG107507 A BG 107507A
Authority
BG
Bulgaria
Prior art keywords
alkyl
mono
radical
alkylamino
unsubstituted
Prior art date
Application number
BG107507A
Other languages
Bulgarian (bg)
English (en)
Inventor
Peter Emig
Eckhard Gunther
Silke Baasner
Gerald Bacher
Thomas Beckers
Beate Aue
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of BG107507A publication Critical patent/BG107507A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107507A 2000-07-21 2003-01-30 Акридинови производни и тяхното използване като лекарствени средства BG107507A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
PCT/EP2001/008263 WO2002008194A1 (fr) 2000-07-21 2001-07-18 Derives acridine et utilisation en tant qu'agents pharmaceutiques

Publications (1)

Publication Number Publication Date
BG107507A true BG107507A (bg) 2003-09-30

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107507A BG107507A (bg) 2000-07-21 2003-01-30 Акридинови производни и тяхното използване като лекарствени средства

Country Status (29)

Country Link
US (1) US6706722B2 (fr)
EP (1) EP1301485B1 (fr)
JP (1) JP2004504382A (fr)
KR (1) KR20030022296A (fr)
CN (1) CN1296359C (fr)
AR (1) AR033383A1 (fr)
AT (1) ATE365717T1 (fr)
AU (2) AU8967501A (fr)
BG (1) BG107507A (fr)
BR (1) BR0112591A (fr)
CA (1) CA2353360A1 (fr)
CY (1) CY1106890T1 (fr)
CZ (1) CZ2003427A3 (fr)
DE (2) DE10035927A1 (fr)
DK (1) DK1301485T3 (fr)
ES (1) ES2291349T3 (fr)
HK (1) HK1057549A1 (fr)
HU (1) HUP0303729A3 (fr)
IL (1) IL153476A0 (fr)
MX (1) MXPA02012564A (fr)
NO (1) NO324939B1 (fr)
NZ (1) NZ524155A (fr)
PL (1) PL358808A1 (fr)
PT (1) PT1301485E (fr)
RU (1) RU2267488C2 (fr)
SK (1) SK1932003A3 (fr)
UA (1) UA75085C2 (fr)
WO (1) WO2002008194A1 (fr)
ZA (1) ZA200210411B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
EP1517898A1 (fr) * 2002-06-29 2005-03-30 Zentaris GmbH Aryl- et heteroarylcarbonylpiperazines et leur utilisation dans le traitement de maladies tumorales benignes et malignes
JP2005537258A (ja) * 2002-07-17 2005-12-08 ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規アントラセン誘導体及び医薬品としてのその使用
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
PE20050226A1 (es) * 2003-06-04 2005-05-18 Aventis Pharma Sa Productos aril-heteroaromaticos y composiciones que los contienen
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
EP1853594A2 (fr) * 2005-01-27 2007-11-14 Alma Mater Studiorum -Universita' di Bologna Composes organiques convenant pour le traitement de la maladie d'alzheimer, utilisation et methode de fabrication
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
WO2008106128A2 (fr) * 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. Inhibiteurs d'urée et de carbamate de 11b-hydroxystéroïde déshydrogénase 1 cycliques
JP5470557B2 (ja) * 2007-07-26 2014-04-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の環状尿素阻害剤
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) * 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009102428A2 (fr) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. INHIBITEURS 1,3-OXAZEPAN-2-ONE ET 1,3-DIAZEPAN-2-ONE DE LA 11β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE (TYPE1)
CA2715290A1 (fr) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibiteurs de la 11 beta-hydroxysteroide dehydrogenase 1
EP2274287B1 (fr) * 2008-03-18 2016-03-09 Vitae Pharmaceuticals, Inc. Inhibiteurs de la 11-bêta-hydroxystéroïde déshydrogénase de type 1
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009134387A1 (fr) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déhydrogénase 1
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (fr) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8637505B2 (en) 2009-02-04 2014-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
GEP20156309B (en) * 2009-04-30 2015-07-10 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (fr) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones comme inhibiteurs de 11-β-hsd1 pour le traitement de troubles métaboliques
EA201300522A1 (ru) 2010-11-02 2013-11-29 Бёрингер Ингельхайм Интернациональ Гмбх Фармацевтические комбинации для лечения метаболических нарушений

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
RU2146254C1 (ru) * 1996-06-29 2000-03-10 Самдзин Фармасьютикал Ко., Лтд. Производные пиперазина и способ их получения
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
KR20010082184A (ko) 1998-08-28 2001-08-29 추후제출 p38-α 키나제의 저해체
WO2000051614A1 (fr) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibiteurs de prenyl-proteine transferases

Also Published As

Publication number Publication date
CA2353360A1 (fr) 2002-01-21
CZ2003427A3 (cs) 2003-06-18
DE10035927A1 (de) 2002-03-07
CY1106890T1 (el) 2012-09-26
AU8967501A (en) 2002-02-05
PT1301485E (pt) 2007-08-30
JP2004504382A (ja) 2004-02-12
DE50112669D1 (de) 2007-08-09
AU2001289675B2 (en) 2005-04-07
WO2002008194A1 (fr) 2002-01-31
ZA200210411B (en) 2003-02-26
HUP0303729A3 (en) 2009-01-28
WO2002008194A8 (fr) 2003-05-08
SK1932003A3 (en) 2003-10-07
ATE365717T1 (de) 2007-07-15
CN1443172A (zh) 2003-09-17
NZ524155A (en) 2005-04-29
EP1301485A1 (fr) 2003-04-16
KR20030022296A (ko) 2003-03-15
DK1301485T3 (da) 2007-11-05
ES2291349T3 (es) 2008-03-01
PL358808A1 (en) 2004-08-23
BR0112591A (pt) 2003-07-22
MXPA02012564A (es) 2003-09-22
EP1301485B1 (fr) 2007-06-27
RU2267488C2 (ru) 2006-01-10
US6706722B2 (en) 2004-03-16
HK1057549A1 (en) 2004-04-08
NO20030301D0 (no) 2003-01-20
IL153476A0 (en) 2003-07-06
NO324939B1 (no) 2008-01-07
HUP0303729A2 (hu) 2004-03-01
UA75085C2 (en) 2006-03-15
NO20030301L (no) 2003-03-11
CN1296359C (zh) 2007-01-24
US20020132821A1 (en) 2002-09-19
AR033383A1 (es) 2003-12-17

Similar Documents

Publication Publication Date Title
BG107507A (bg) Акридинови производни и тяхното използване като лекарствени средства
BG107508A (bg) Нови хетероарилови производни и тяхното използване като лекарствени средства
BG107506A (bg) Нови хетероарилови производни и тяхното използване като лекарствени средства
US7989453B2 (en) Indole derivatives and their use as medicament
CN113527195B (zh) 一类5-芳基烟酰胺类lsd1/hdac双靶点抑制剂、其制备方法及应用
CA2435399A1 (fr) Nouveaux derives de l'anthracene et leur utilisation comme preparations pharmaceutiques